Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
23andMe Holding Co. operates as a consumer genetics testing company in the United States, the United Kingdom, Canada, and internationally. The company operates in two segments, Consumer and Research Services, and Therapeutics. The Consumer and Research Services segment provides personal genome service (PGS) that consists of a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications. This segments also operates Lemonaid telehealth platform to access affiliated licensed healthcare professionals for medical consultation and treatment for various common conditions; and offers research services. The Therapeutics segment focuses on the development of novel therapies; and research and development of programs in various therapeutic areas, such as oncology, immunological and inflammatory diseases, and other disease areas, as well as engages in the out-licensing of intellectual property associated with identified drug targets and expenses related to the discovery and development of therapeutic product candidates. This segment also comprises a therapeutics product portfolio, including 23ME-00610 (P006), a humanized monoclonal antibody that interfere with the ability of CD200R1 to interact with CD200 in cancer cells; GSK6097608, an immuno-oncology program for targeting CD96; and 23ME-01473 is an immuno-oncology antibody program that targets the ULBP6 proteins in the NKG2D pathway. 23andMe Holding Co. was founded in 2006 and is headquartered in South San Francisco, California. more
Time Frame | ME | Sector | S&P500 |
---|---|---|---|
1-Week Return | -2.39% | -2.12% | -3% |
1-Month Return | 3.81% | -3.42% | -0.73% |
3-Month Return | -51.91% | -11.13% | 2.87% |
6-Month Return | -60.86% | -5.74% | 7.17% |
1-Year Return | -81.47% | 3.97% | 25.31% |
3-Year Return | -97.53% | 1.05% | 28.38% |
5-Year Return | -98.33% | 34.37% | 81.89% |
Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 305.46M | 243.92M | 271.89M | 299.49M | 219.64M | [{"date":"2020-03-31","value":100,"profit":true},{"date":"2021-03-31","value":79.85,"profit":true},{"date":"2022-03-31","value":89.01,"profit":true},{"date":"2023-03-31","value":98.04,"profit":true},{"date":"2024-03-31","value":71.9,"profit":true}] |
Cost of Revenue | 168.03M | 126.91M | 138.95M | 164.99M | 120.26M | [{"date":"2020-03-31","value":100,"profit":true},{"date":"2021-03-31","value":75.53,"profit":true},{"date":"2022-03-31","value":82.69,"profit":true},{"date":"2023-03-31","value":98.19,"profit":true},{"date":"2024-03-31","value":71.57,"profit":true}] |
Gross Profit | 137.43M | 117.01M | 132.94M | 134.50M | 99.38M | [{"date":"2020-03-31","value":100,"profit":true},{"date":"2021-03-31","value":85.14,"profit":true},{"date":"2022-03-31","value":96.74,"profit":true},{"date":"2023-03-31","value":97.86,"profit":true},{"date":"2024-03-31","value":72.31,"profit":true}] |
Gross Margin | 44.99% | 47.97% | 48.90% | 44.91% | 45.25% | [{"date":"2020-03-31","value":92.01,"profit":true},{"date":"2021-03-31","value":98.1,"profit":true},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":91.84,"profit":true},{"date":"2024-03-31","value":92.53,"profit":true}] |
Operating Expenses | 351.19M | 302.20M | 387.10M | 458.51M | 420.73M | [{"date":"2020-03-31","value":76.59,"profit":true},{"date":"2021-03-31","value":65.91,"profit":true},{"date":"2022-03-31","value":84.43,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":91.76,"profit":true}] |
Operating Income | (213.75M) | (185.20M) | (254.15M) | (324.01M) | (321.36M) | [{"date":"2020-03-31","value":-21375500000,"profit":false},{"date":"2021-03-31","value":-18519600000,"profit":false},{"date":"2022-03-31","value":-25415300000,"profit":false},{"date":"2023-03-31","value":-32401100000,"profit":false},{"date":"2024-03-31","value":-32135600000,"profit":false}] |
Total Non-Operating Income/Expense | (30.86M) | 3.15M | 33.46M | 19.26M | (330.94M) | [{"date":"2020-03-31","value":-92.24,"profit":false},{"date":"2021-03-31","value":9.43,"profit":true},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":57.56,"profit":true},{"date":"2024-03-31","value":-989.07,"profit":false}] |
Pre-Tax Income | (250.86M) | (183.62M) | (220.97M) | (314.43M) | (666.63M) | [{"date":"2020-03-31","value":-25086300000,"profit":false},{"date":"2021-03-31","value":-18361900000,"profit":false},{"date":"2022-03-31","value":-22097000000,"profit":false},{"date":"2023-03-31","value":-31442800000,"profit":false},{"date":"2024-03-31","value":-66663100000,"profit":false}] |
Income Taxes | 38.45M | (255.00K) | (3.48M) | (2.77M) | 73.00K | [{"date":"2020-03-31","value":100,"profit":true},{"date":"2021-03-31","value":-0.66,"profit":false},{"date":"2022-03-31","value":-9.05,"profit":false},{"date":"2023-03-31","value":-7.21,"profit":false},{"date":"2024-03-31","value":0.19,"profit":true}] |
Income After Taxes | (289.31M) | (183.36M) | (217.49M) | (311.66M) | (666.70M) | [{"date":"2020-03-31","value":-28931100000,"profit":false},{"date":"2021-03-31","value":-18336400000,"profit":false},{"date":"2022-03-31","value":-21749000000,"profit":false},{"date":"2023-03-31","value":-31165600000,"profit":false},{"date":"2024-03-31","value":-66670400000,"profit":false}] |
Income From Continuous Operations | (250.86M) | (183.62M) | (217.49M) | (311.66M) | (666.70M) | [{"date":"2020-03-31","value":-25086300000,"profit":false},{"date":"2021-03-31","value":-18361900000,"profit":false},{"date":"2022-03-31","value":-21749000000,"profit":false},{"date":"2023-03-31","value":-31165600000,"profit":false},{"date":"2024-03-31","value":-66670400000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2020-03-31","value":"-","profit":true},{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true}] |
Net Income | (289.31M) | (183.36M) | (217.49M) | (311.66M) | (666.70M) | [{"date":"2020-03-31","value":-28931100000,"profit":false},{"date":"2021-03-31","value":-18336400000,"profit":false},{"date":"2022-03-31","value":-21749000000,"profit":false},{"date":"2023-03-31","value":-31165600000,"profit":false},{"date":"2024-03-31","value":-66670400000,"profit":false}] |
EPS (Diluted) | (0.38) | (1.93) | (0.70) | (0.51) | (0.66) | [{"date":"2020-03-31","value":-38.23,"profit":false},{"date":"2021-03-31","value":-192.55,"profit":false},{"date":"2022-03-31","value":-70,"profit":false},{"date":"2023-03-31","value":-51,"profit":false},{"date":"2024-03-31","value":-66,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
ME | |
---|---|
Cash Ratio | 0.83 |
Current Ratio | 1.24 |
Quick Ratio | 1.14 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
ME | |
---|---|
ROA (LTM) | -25.77% |
ROE (LTM) | -154.21% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
ME | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.68 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.32 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
ME | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 0.43 |
P/B | 0.84 |
Price/FCF | NM |
EV/R | 0.16 |
EV/Ebitda | NM |
23Andme Holding Co (ME) share price today is $3.27
Yes, Indians can buy shares of 23Andme Holding Co (ME) on Vested. To buy 23Andme Holding Co from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ME stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of 23Andme Holding Co (ME) via the Vested app. You can start investing in 23Andme Holding Co (ME) with a minimum investment of $1.
You can invest in shares of 23Andme Holding Co (ME) via Vested in three simple steps:
The 52-week high price of 23Andme Holding Co (ME) is $19.34. The 52-week low price of 23Andme Holding Co (ME) is $2.65.
The price-to-earnings (P/E) ratio of 23Andme Holding Co (ME) is
The price-to-book (P/B) ratio of 23Andme Holding Co (ME) is 0.84
The dividend yield of 23Andme Holding Co (ME) is 0.00%
The market capitalization of 23Andme Holding Co (ME) is $79.92M
The stock symbol (or ticker) of 23Andme Holding Co is ME